Study To Assess Long Term Safety Of Pazopanib

NCT00387205 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Pazopanib

Sponsor

Novartis Pharmaceuticals